CoChat

Selective pharmacogenetic inhibition of mammalian target of Rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage

Open access
Stoica, Loredana, Zhu, Ping Jun, Huang, Wei, Zhou, Hongyi, Kozma, Sara C., Costa-Mattioli, Mauro · 2011 · Proceedings of the National Academy of Sciences

The DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index.

Abstract

Both the formation of long-term memory (LTM) and late-long-term potentiation (L-LTP), which is thought to represent the cellular model of learning and memory, require de novo protein synthesis. The mammalian target of Rapamycin (mTOR) complex I (mTORC1) integrates information from various synaptic inputs and its best characterized function is the regulation of translation. Although initial studies have shown that rapamycin reduces L-LTP and partially blocks LTM, recent genetic and pharmacological evidence indicating that mTORC1 promotes L-LTP and LTM is controversial. Thus, the role of mTORC1 in L-LTP and LTM is unclear. To selectively inhibit mTORC1 activity in the adult brain, we used a “pharmacogenetic” approach that relies on the synergistic action of a drug (rapamycin) and a genetic manipulation (mTOR heterozygotes, mTOR +/− mice) on the same target (mTORC1). Although L-LTP and LTM are normal in mTOR +/− mice, application of a low concentration of rapamycin—one that is subthreshold for WT mice—prevented L-LTP and LTM only in mTOR +/− mice. Furthermore, we found that mTORC1-mediated translational control is required for memory reconsolidation. We provide here direct genetic evidence supporting the role of mTORC1 in L-LTP and behavioral memory.

Overview

Integrity signals

Registry

Crossref · 10.1073/pnas.1014715108

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 56 references

Research works printed but not linked: 1

  1. 10.1128/mcb.13.10.6012-6023.1993 · doi:10.1128/mcb.13.10.6012-6023.1993 · Paper page

Cited by

See all 233

Metadata

Authors
Stoica, L., Zhu, P. J., Huang, W., Zhou, H., Kozma, S. C., & Costa-Mattioli, M.
Affiliations
  • Baylor College of Medicine (US)
  • University of California, Irvine (US)
  • University of Cincinnati (US)
  • Departments of aNeuroscience and
Venue
Proceedings of the National Academy of Sciences
Published
2011-02-09
Volume
108
Issue
9
Pages
3791-3796
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2135133717
Cited by
232
References
57
Citations by year
2026: 11 · 2025: 11 · 2024: 10 · 2023: 9 · 2022: 12 · 2021: 15 · 2020: 14 · 2019: 19 · 2018: 17 · 2017: 16 · 2016: 16 · 2015: 18 · 2014: 19 · 2013: 25 · 2012: 15
FWCI
10.40
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
Whitehall Foundation
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords
mTORC1, long-term memory, synaptic plasticity, memory reconsolidation, translational regulation, rapamycin, de novo protein synthesis, learning and memory
MeSH terms
Mechanistic Target of Rapamycin Complex 1, Acoustic Stimulation, Animals, Fear, Pharmacogenetics, Proteins, Transcription Factors, Trans-Activators, Long-Term Potentiation, Sirolimus, Multiprotein Complexes, Mice, Memory, Long-Term, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Selective pharmacogenetic inhibition of mammalian target of Rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage. https://app.cochat.ai/papers/10.1073/pnas.1014715108
The paper
Stoica, L., Zhu, P. J., Huang, W., Zhou, H., Kozma, S. C., & Costa-Mattioli, M. (2011). Selective pharmacogenetic inhibition of mammalian target of Rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1014715108

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.